These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15028887)

  • 1. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic status of p53 gene mutation in canine mammary carcinoma.
    Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
    Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
    Klopfleisch R; Klose P; Gruber AD
    Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene p53 mutations and overexpression of p53 protein in tumors of the Vater's ampulla].
    Terris B; Muzeau F; Sauvanet A; Belghiti J; Fléjou JF
    Gastroenterol Clin Biol; 1998 May; 22(5):495-9. PubMed ID: 9762287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs.
    Gamblin RM; Sagartz JE; Couto CG
    Am J Vet Res; 1997 Aug; 58(8):857-63. PubMed ID: 9256970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands.
    Klopfleisch R; Gruber AD
    Res Vet Sci; 2009 Aug; 87(1):91-6. PubMed ID: 19185891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors.
    Akiyoshi T; Uchida K; Tateyama S
    Vet Pathol; 2004 Mar; 41(2):154-63. PubMed ID: 15017029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.